Giant cell arteritis: Diagnostic accuracy of mr imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial

Radiology

Volumn 273, Issue 3, 2014, Pages 844-852

  Klink, Thorsten ^a,e   Geiger, Julia ^b   Both, Marcus ^c   Ness, Thomas ^b   Heinzelmann, Sonja ^b   Reinhard, Matthias ^b   Holl Ulrich, Konstanze ^d   Duwendag, Dirk ^c   Vaith, Peter ^b   Bley, Thorsten Alexander ^e  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CONTRAST MEDIUM; GADOBUTROL; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTERY; ARTICLE; BLOOD VESSEL BIOPSY; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRANIAL ARTERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFECT; FEMALE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PROSPECTIVE STUDY; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; CLINICAL TRIAL; DIAGNOSTIC USE; MIDDLE AGED; PATHOLOGY; PROCEDURES; TEMPORAL ARTERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GIANT CELL ARTERITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERIES;

EID: 84910110032     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14140056     Document Type: Article

References (23)

1. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009;61(10):1454-1461
2. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: A population-based study over 50 years. Arthritis Rheum 2003;48(12):3532-3537
3. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372(9634):234-245
4. Wilkinson IM, Russell RW. Arteries of the head and neck in giant cell arteritis: A pathological study to show the pattern of arterial involvement. Arch Neurol 1972;27(5):378-391
5. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976;51(8):504-510
6. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33(8):1122-1128
7. Proven A, Gabriel SE, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49(5):703-708
8. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347(4):261-271
9. Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 2007;28(9):1722-1727
10. Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 2005;184(1):283-287
11. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Radiology 2003;226(1):24-28
12. Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford, England: Oxford University Press, 2003
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174
14. DeLong ER, Vernon WB, Bollinger RR. Sensitivity and specificity of a monitoring test. Biometrics 1985;41(4):947-958
15. Bley TA, Weiben O, Uhl M, et al. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum 2005;52(8):2470-2477
16. Ypsilantis E, Courtney ED, Chopra N, et al. Importance of specimen length during temporal artery biopsy. Br J Surg 2011;98(11): 1556-1560
17. Niederkohr RD, Levin LA. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci 2007;48(2):675-680
18. Alberts MS, Mosen DM. Diagnosing temporal arteritis: duplex vs. biopsy. QJM 2007; 100(12):785-789
19. Bley TA, Markl M, Schelp M, et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology (Oxford) 2008;47(1):65-67
20. Hauenstein C, Reinhard M, Geiger J, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford) 2012;51(11):1999-2003
21. Takekawa H, Daimon Y, Takashima R, Aiba S, Tanaka H, Hirata K. Giant cell arteritis associated with lesion of the internal carotid artery: Assessment of response to steroid therapy by magnetic resonance angiography. Intern Med 2008;47(13):1285-1286
22. Bley TA, Ness T, Warnatz K, et al. Influence of corticosteroid treatment on MRI findings in giant cell arteritis. Clin Rheumatol 2007;26(9):1541-1543
23. Narváez J, Bernad B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 2007;37(1):13-19